NCT01187199 2025-10-27Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerM.D. Anderson Cancer CenterPhase 1 Active not recruiting278 enrolled